This week, the White House made several statements regarding the shortage of infant formula across the nation. On Feb. 17, the agency warned consumers not to use certain powdered infant formula products from Abbott Nutrition’s Sturgis, Michigan facility, and Abbott initiated a voluntary recall of certain products.
On Monday, May 10th, 2022, the White House put out a press release highlighting the steps being taken by the FDA to address the shortage, listing several actions underway to help relieve the crisis, such as meetings, monitoring production and importation, and expediting processes in bringing products to the market. In particular, the statement made clear that, “the agency continues to advise against making infant formulas at home and encourages caregivers to work with their child’s health care provider for recommendations on changing feeding practices, if needed.”
The White House promised that “the FDA will continue to dedicate all available resources to help ensure that infant formula products remain available for use in the U.S. and will keep the public informed of progress updates.”
On Wednesday, the White House released a Fact Sheet announcing additional measures, including cutting red tape on the types of formula parents can buy, calling on the Federal Trade Commission and state attorneys general to crack down on price gouging and unfair market practices, and increasing the supply of formula through increased imports.
On Thursday, the Department of Health and Human Services released a list of resources for families who need assistance locating and purchasing formula. This fact sheet includes:
- Manufacturer Hotlines
- Community Resources
- Guidance for Families Eligible for WIC
- General Guidance
